HK1035710A1 - Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl-l-carnitines - Google Patents
Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl-l-carnitinesInfo
- Publication number
- HK1035710A1 HK1035710A1 HK01104772A HK01104772A HK1035710A1 HK 1035710 A1 HK1035710 A1 HK 1035710A1 HK 01104772 A HK01104772 A HK 01104772A HK 01104772 A HK01104772 A HK 01104772A HK 1035710 A1 HK1035710 A1 HK 1035710A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- solid compositions
- carnitines
- carnitine
- oral administration
- alkanoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98RM000445A IT1299544B1 (it) | 1998-07-03 | 1998-07-03 | Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine |
| PCT/IT1999/000202 WO2000001662A1 (en) | 1998-07-03 | 1999-07-02 | Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1035710A1 true HK1035710A1 (en) | 2001-12-07 |
Family
ID=11406029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK01104772A HK1035710A1 (en) | 1998-07-03 | 2001-07-10 | Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl-l-carnitines |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6465515B2 (xx) |
| EP (1) | EP1093451B1 (xx) |
| JP (1) | JP2002519403A (xx) |
| KR (1) | KR100642729B1 (xx) |
| AT (1) | ATE248805T1 (xx) |
| AU (1) | AU4647999A (xx) |
| CA (1) | CA2335503A1 (xx) |
| DE (1) | DE69911021T2 (xx) |
| DK (1) | DK1093451T3 (xx) |
| ES (1) | ES2205843T3 (xx) |
| HK (1) | HK1035710A1 (xx) |
| IL (1) | IL140487A (xx) |
| IT (1) | IT1299544B1 (xx) |
| PT (1) | PT1093451E (xx) |
| WO (1) | WO2000001662A1 (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1317048B1 (it) * | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie |
| JP2006111550A (ja) * | 2004-10-13 | 2006-04-27 | Nisshin Pharma Inc | カルニチン含有製品 |
| WO2022258631A1 (en) * | 2021-06-07 | 2022-12-15 | Kaesler Nutrition Gmbh | Carnitine formulation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE51711B1 (en) * | 1977-11-03 | 1987-03-04 | Sigma Tau Ind Farmaceuti | Carnitine derivatives |
| DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
| IT1209564B (it) * | 1984-06-29 | 1989-08-30 | Magis Farmaceutici | Derivati della l-carnitina o di l-acil carnitina. |
| IT1188176B (it) * | 1985-07-05 | 1988-01-07 | Bicresearch Spa | Sali della carnitina particolarmente idonei per uso orale |
| DE3841664A1 (de) * | 1988-12-10 | 1990-10-11 | Fresenius Ag | Nicht-hygroskopisches salz des l-carnitins |
| US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
-
1998
- 1998-07-03 IT IT98RM000445A patent/IT1299544B1/it active IP Right Grant
-
1999
- 1999-07-02 WO PCT/IT1999/000202 patent/WO2000001662A1/en active IP Right Grant
- 1999-07-02 DK DK99929707T patent/DK1093451T3/da active
- 1999-07-02 ES ES99929707T patent/ES2205843T3/es not_active Expired - Lifetime
- 1999-07-02 PT PT99929707T patent/PT1093451E/pt unknown
- 1999-07-02 JP JP2000558067A patent/JP2002519403A/ja active Pending
- 1999-07-02 EP EP99929707A patent/EP1093451B1/en not_active Expired - Lifetime
- 1999-07-02 DE DE69911021T patent/DE69911021T2/de not_active Expired - Fee Related
- 1999-07-02 IL IL14048799A patent/IL140487A/en not_active IP Right Cessation
- 1999-07-02 KR KR1020017000060A patent/KR100642729B1/ko not_active IP Right Cessation
- 1999-07-02 AU AU46479/99A patent/AU4647999A/en not_active Abandoned
- 1999-07-02 AT AT99929707T patent/ATE248805T1/de not_active IP Right Cessation
- 1999-07-02 CA CA002335503A patent/CA2335503A1/en not_active Abandoned
-
2000
- 2000-12-21 US US09/740,786 patent/US6465515B2/en not_active Expired - Fee Related
-
2001
- 2001-07-10 HK HK01104772A patent/HK1035710A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE248805T1 (de) | 2003-09-15 |
| US20010009923A1 (en) | 2001-07-26 |
| EP1093451B1 (en) | 2003-09-03 |
| DK1093451T3 (da) | 2004-01-05 |
| ES2205843T3 (es) | 2004-05-01 |
| ITRM980445A1 (it) | 2000-01-03 |
| PT1093451E (pt) | 2003-12-31 |
| IL140487A (en) | 2004-07-25 |
| KR20010071720A (ko) | 2001-07-31 |
| IL140487A0 (en) | 2002-02-10 |
| EP1093451A1 (en) | 2001-04-25 |
| IT1299544B1 (it) | 2000-03-16 |
| AU4647999A (en) | 2000-01-24 |
| US6465515B2 (en) | 2002-10-15 |
| DE69911021D1 (de) | 2003-10-09 |
| JP2002519403A (ja) | 2002-07-02 |
| KR100642729B1 (ko) | 2006-11-03 |
| DE69911021T2 (de) | 2004-04-01 |
| ITRM980445A0 (it) | 1998-07-03 |
| WO2000001662A1 (en) | 2000-01-13 |
| CA2335503A1 (en) | 2000-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112495A0 (en) | Phenylacetic acid derivatives, their preparation and compositions containing them | |
| ES2092266T5 (es) | Composiciones para la nutricion ingeribles oralmente, que tienen apetibilidad mejorada. | |
| WO1996017587A3 (en) | Oral compositions containing stabilized stannous compounds | |
| ES2173400T3 (es) | Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido. | |
| CY1112139T1 (el) | Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης | |
| NZ511085A (en) | Oral pharmaceutical compositions containing buprenorphin | |
| FI853763L (fi) | 1,3-dimetyl-1h-purin-2,6-dioner, som innehaoller 1h-indol-3-yl. | |
| EP0104768A3 (en) | Oral compositions comprising ng-acyl derivatives of arginine | |
| CA2344686A1 (en) | High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
| HK1035710A1 (en) | Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl-l-carnitines | |
| HK1005454A1 (en) | Pure crystalline form of refapentine | |
| PL367812A1 (en) | Alpha-ketoglutarates of active ingredients and compositions containing same | |
| AU9589301A (en) | Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride | |
| PL342165A1 (en) | Antienzymic composition containing ethylenediamino disuscinic acid | |
| BR9808461A (pt) | Método para composições sólidas adequadas para administração oral compreendendo sais não higroscópicos de l-carnitina e alcanoil-l-carnitina com ácido 2-aminoetassulfÈnico. | |
| IL71068A0 (en) | N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it | |
| AU6725300A (en) | Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same | |
| NZ216111A (en) | 4(z)-6-((2,4,5-cis -4-o-hydroxyphenyl-2-trifluoro-methyl-1,3-dioxan-5-yl) hexanoic acid, pharmaceutical salts and pharmaceutical compositions thereof; ethers thereof | |
| TH51539A (xx) | ||
| UY24851A1 (es) | Derivados de ácidos n-acil-alfa-aminados | |
| UA33859A (uk) | Композиція інгредієнтів для горілки особливої "premium nemiroff" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080702 |